An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.
Missailidis, Daniel, Annesley, Sarah J, Allan, Claire Y et al. · International journal of molecular sciences · 2020 · DOI
Quick Summary
Researchers studied the energy-producing structures (mitochondria) in blood cells from ME/CFS patients and found a specific problem: the cells have difficulty using a protein complex called Complex V that normally makes ATP, the body's energy currency. To compensate, the cells turn up their other energy-making machinery, which keeps ATP levels normal while resting but may leave the cells exhausted when they need to produce extra energy quickly—similar to running a car engine at maximum capacity just to maintain normal speed.
Why It Matters
This study identifies a specific mitochondrial defect in ME/CFS patients—Complex V inefficiency—and explains a potential mechanism for post-exertional malaise: cells may be unable to meet acute energy demands because their compensatory pathways are already maximally activated at rest. Understanding this molecular abnormality could guide development of targeted treatments and validates the long-suspected role of mitochondrial dysfunction in ME/CFS pathology.
Observed Findings
Complex V ATP synthesis rate was significantly reduced as a proportion of basal oxygen consumption in ME/CFS lymphoblasts.
Complex I oxygen consumption rate, maximum oxygen consumption, and spare respiratory capacity were elevated in ME/CFS cells.
Mitochondrial membrane potential was reduced in ME/CFS lymphoblasts.
TOR Complex I stress signaling was chronically hyperactivated in ME/CFS cells.
Steady-state ATP levels, mitochondrial mass, and glycolytic rates were unchanged between ME/CFS and control cells.
Inferred Conclusions
ME/CFS lymphoblasts compensate for Complex V deficiency by upregulating respiratory complexes and fatty acid oxidation, maintaining normal ATP levels at rest.
The compensatory activation of energy production pathways may leave cells unable to respond to acute increases in energy demand, potentially explaining post-exertional malaise.
Mitochondrial dysfunction in ME/CFS involves dysregulated energy sensing (chronically elevated TOR signaling) rather than absolute energy deficit.
Remaining Questions
Does the Complex V defect occur in other tissue types (muscle, neurons) or is it specific to lymphocytes?
Can acute metabolic challenges (stimulus-response testing) reveal the predicted inability to meet increased energy demand in ME/CFS cells?
What This Study Does Not Prove
This study does not prove that Complex V deficiency causes ME/CFS or that it occurs in all patients, as it examined only immortalized lymphoblasts from a single timepoint. The findings correlate with ME/CFS diagnosis but cannot establish causation or demonstrate whether this defect is primary, secondary, or tissue-specific. Additionally, the study does not show whether correcting Complex V function would improve patient symptoms.